Clinical Trials Logo

Clinical Trial Summary

This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol) at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.


Clinical Trial Description

Post-operative infections, although rare, can lead to significant patient morbidity and cost. A potential risk factor for the development of post-operative wound infection is the amount of bacterial skin flora present at the operative site at the time of surgery. Therefore, the use of an effective anti-microbial preoperative skin-preparation solution is essential in preventing the contamination of the surgical site and in turn the surgical wound.

Several different types of anti-microbial skin preparation solutions are presently used pre-operatively. However, there is currently no consensus on which solution is superior. Previous studies have investigated the efficacy of commonly used solutions in the shoulder, foot and spine, however the bacterial flora from these areas are likely different from the hip region. Thus the findings in the literature are not necessarily applicable to surgery involving the hip.

Because of the potentially devastating consequences of a surgical wound infection, ensuring effective skin preparation prior to surgery is critical. Therefore the identification of a superior skin-preparation solution for the elimination of bacterial pathogens, specific to the hip region, could potentially have considerable impact on the clinical care of patients undergoing hip arthroplasty surgery.

This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol), at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.The primary outcome is as follows: positive culture rates of residual bacteria following surgical skin preparation. Secondary outcomes that will be evaluated is culture rates post-surgery (following skin closure) and acute (within 3 months) post-operative wound complications. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03393819
Study type Interventional
Source Lakehead University
Contact
Status Completed
Phase N/A
Start date October 29, 2014
Completion date April 6, 2016

See also
  Status Clinical Trial Phase
Completed NCT02580214 - Immunonutrition in Total Hip Arthroplasty Phase 2/Phase 3
Completed NCT02839876 - Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty Phase 4
Recruiting NCT06107296 - Early Perioperative Quality Of Recovery After Hip and Knee Arthroplasty: a Retrospective Comparative Cohort Study
Recruiting NCT03806114 - Dislocation Precautions N/A
Completed NCT02342236 - Cerebral Regional Oxygen Saturation and Markers of Brain Damage During Primary Hip Arthroplasty N/A
Completed NCT01514006 - Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty N/A
Completed NCT02338661 - Clinical Observation Study With the SBG Stem